LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma

[1]  C. Lareau,et al.  Single-cell chromatin state analysis with Signac , 2021, Nature Methods.

[2]  R. Simms,et al.  Systemic sclerosis , 2015, Nature Reviews Disease Primers.

[3]  J. Varga,et al.  Linking autoimmunity, short telomeres and lung fibrosis in SSc , 2021, Nature Reviews Rheumatology.

[4]  R. Domsic,et al.  Single-cell transcriptome analysis identifies skin-specific T-cell responses in systemic sclerosis , 2021, Annals of the Rheumatic Diseases.

[5]  R. Bourgon,et al.  Cross-tissue organization of the fibroblast lineage , 2021, Nature.

[6]  A. Papazoglou,et al.  Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin , 2021, Nature Communications.

[7]  I. Amit,et al.  Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing , 2021, Nature Medicine.

[8]  M. Araúzo-Bravo,et al.  Human dermal fibroblast subpopulations are conserved across single-cell RNA sequencing studies. , 2020, The Journal of investigative dermatology.

[9]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[10]  G. Kang,et al.  SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers , 2020, Scientific Reports.

[11]  R. Krüger,et al.  The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides , 2020, Nature Communications.

[12]  J. Mallm,et al.  Single-cell transcriptomes of the human skin reveal age-related loss of fibroblast priming , 2020, Communications Biology.

[13]  I. Amit,et al.  Lgr5+ telocytes are a signaling source at the intestinal villus tip , 2020, Nature Communications.

[14]  W. Marut,et al.  Novel insights into dendritic cells in the pathogenesis of systemic sclerosis , 2020, Clinical and experimental immunology.

[15]  B. Hinz,et al.  Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases , 2019, Nature Reviews Rheumatology.

[16]  A. Tanay,et al.  MetaCell: analysis of single-cell RNA-seq data using K-nn graph partitions , 2019, Genome Biology.

[17]  Fred A. Hamprecht,et al.  ilastik: interactive machine learning for (bio)image analysis , 2019, Nature Methods.

[18]  B. Ghanim,et al.  IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis , 2019, European Respiratory Journal.

[19]  Shinichi Sato,et al.  Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study , 2019, Arthritis Research & Therapy.

[20]  Amos Tanay,et al.  MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing , 2019, Nature Protocols.

[21]  O. Distler,et al.  Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis , 2019, Nature Reviews Rheumatology.

[22]  M. Rojas,et al.  Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease , 2019, Annals of the Rheumatic Diseases.

[23]  Qing Nie,et al.  Single-cell analysis reveals fibroblast heterogeneity and myeloid-derived adipocyte progenitors in murine skin wounds , 2019, Nature Communications.

[24]  I. Amit,et al.  Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma , 2019, Cell.

[25]  I. Amit,et al.  Lung Single-Cell Signaling Interaction Map Reveals Basophil Role in Macrophage Imprinting , 2018, Cell.

[26]  Michael J. T. Stubbington,et al.  Single-cell reconstruction of the early maternal–fetal interface in humans , 2018, Nature.

[27]  M. Reynaud‐Gaubert,et al.  Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release , 2018, Front. Immunol..

[28]  M. Grainge,et al.  The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink , 2018, Clinical Rheumatology.

[29]  F. Watt,et al.  Spatial and Single-Cell Transcriptional Profiling Identifies Functionally Distinct Human Dermal Fibroblast Subpopulations , 2018, The Journal of investigative dermatology.

[30]  J. Duffield,et al.  Tissue-resident mesenchymal stromal cells: Implications for tissue-specific antifibrotic therapies , 2018, Science Translational Medicine.

[31]  Wei Chen,et al.  SFRP2/DPP4 and FMO1/LSP1 Define Major Fibroblast Populations in Human Skin. , 2017, The Journal of investigative dermatology.

[32]  P. Richardson,et al.  Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation , 2017, The Journal of Biological Chemistry.

[33]  R. Marangoni,et al.  The roles of dermal white adipose tissue loss in scleroderma skin fibrosis , 2017, Current opinion in rheumatology.

[34]  Yan Ding,et al.  HGF/R-spondin1 rescues liver dysfunction through the induction of Lgr5+ liver stem cells , 2017, Nature Communications.

[35]  C. Denton,et al.  SYSTEMIC SCLEROSIS , 2008 .

[36]  A. Regev,et al.  Anatomically and Functionally Distinct Lung Mesenchymal Populations Marked by Lgr5 and Lgr6 , 2017, Cell.

[37]  R. Knobler,et al.  Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment , 2017, American Journal of Clinical Dermatology.

[38]  Paul Martin,et al.  Inflammation and metabolism in tissue repair and regeneration , 2017, Science.

[39]  H. Binder,et al.  Multilineage communication regulates human liver bud development from pluripotency , 2017, Nature.

[40]  T. Fest,et al.  CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis , 2017, Clinical Rheumatology.

[41]  Piero Carninci,et al.  A draft network of ligand–receptor-mediated multicellular signalling in human , 2015, Nature Communications.

[42]  A. Postlethwaite,et al.  Pathogenesis of Systemic Sclerosis , 2015, Front. Immunol..

[43]  M. Fritzler,et al.  Autoantibodies in Systemic Sclerosis: Unanswered Questions , 2015, Front. Immunol..

[44]  I. Amit,et al.  Massively Parallel Single-Cell RNA-Seq for Marker-Free Decomposition of Tissues into Cell Types , 2014, Science.

[45]  S. Jimenez,et al.  Altered MCM Protein Levels and Autophagic Flux in Aged and Systemic Sclerosis Dermal Fibroblasts , 2014, The Journal of investigative dermatology.

[46]  M. Mayes,et al.  An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative , 2013 .

[47]  Lester F. Lau,et al.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets , 2011, Nature Reviews Drug Discovery.

[48]  M. York.  Novel insights on the role of the innate immune system in systemic sclerosis , 2011, Expert review of clinical immunology.

[49]  M. Trojanowska.  Cellular and molecular aspects of vascular dysfunction in systemic sclerosis , 2010, Nature Reviews Rheumatology.

[50]  Hans Clevers,et al.  Lgr5 marks cycling, yet long-lived, hair follicle stem cells , 2008, Nature Genetics.

[51]  H. Clevers,et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.

[52]  Kevin Wei,et al.  A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development , 2006, The Journal of experimental medicine.

[53]  B. Hirschel,et al.  GRANULATION TISSUE AS A CONTRACTILE ORGAN: A STUDY OF STRUCTURE AND FUNCTION , 1972 .

[54]  S. Bhattacharyya,et al.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities , 2012, Nature Reviews Rheumatology.

[55]  T. Medsger,et al.  Assessment of disease severity and prognosis. , 2003, Clinical and experimental rheumatology.